Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  ACS Chemical Neuroscience

• Publication date

  2017-08-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschemneuro.7b00126PMID 28731692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CholesteroNitrones for Stroke.

  2015cited by this paper
• The Translational Repressor eIF4E-Binding Protein 2 (4E-BP2) Correlates with Selective Delayed Neuronal Death after Ischemia

  2013cited by this paper
• Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.

  2013cited by this paper
• Safety and Efficacy of Mechanical Thrombectomy with Solitaire Stent Retrieval for Acute Ischemic Stroke: A Systematic Review

  2012cited by this paper
• Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics.

  2012cited by this paper
• Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.

  2012cited by this paper
• A new method for focal transient cerebral ischaemia by distal compression of the middle cerebral artery

  2012cited by this paper
• Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models

  2012cited by this paper
• Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.

  2011cited by this paper
• De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays

  2011cited by this paper
• Post-stroke pharmacological intervention: promoting brain recovery from injury in the future.

  2010cited by this paper
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

  2010cited by this paper
• Occurrence and Predictors of Futile Recanalization following Endovascular Treatment among Patients with Acute Ischemic Stroke: A Multicenter Study

  2010cited by this paper
• The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease

  2009cited by this paper
• Effects of NXY‐059 in experimental stroke: an individual animal meta‐analysis

  2009cited by this paper
• NXY-059 for the Treatment of Acute Stroke: Pooled Analysis of the SAINT I and II Trials

  2008cited by this paper
• Nitrones as therapeutics.

  2008cited by this paper
• Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia.

  2008cited by this paper
• Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging.

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Regulatory proteins of eukaryotic initiation factor 2‐alpha subunit (eIF2α) phosphatase, under ischemic reperfusion and tolerance

  2007cited by this paper
• A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.

  2007cited by this paper
• Therapeutic strategies for the treatment of stroke.

  2006cited by this paper
• Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia.

  2006cited by this paper
• NXY-059 for acute ischemic stroke.

  2006cited by this paper
• Nitrone spin on cerebral ischemia.

  2006cited by this paper
• Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.

  2005cited by this paper
• Oxidants, antioxidants and the ischemic brain

  2004cited by this paper
• Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury

  2004cited by this paper
• Initiation Factor 2B Activity Is Regulated by Protein Phosphatase 1, Which Is Activated by the Mitogen-activated Protein Kinase-dependent Pathway in Insulin-like Growth Factor 1-stimulated Neuronal Cells*

  2003cited by this paper
• Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.

  2003cited by this paper
• The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

  2001cited by this paper
• Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis.

  2000cited by this paper
• Oxidative Stress in Brain Ischemia

  1999cited by this paper
• Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

  1986cited by this paper

• Quinolylnitrone 23 Protects from Auditory Cell Oxidative Injury and Noise-Induced Hearing Loss.

  2025cites this paper
• Targeting Endothelial Progenitor Cells Reparative Potential Via Canonical Wnt/NOX-4 Signaling Pathway in Rats Dyslipidemia: Role of Resveratrol

  2024cites this paper
• Research progress of prodrugs for the treatment of cerebral ischemia.

  2024cites this paper
• Synthesis, antioxidant and neuroprotective analysis of diversely functionalized α-aryl-N-alkyl nitrones as potential agents for ischemic stroke therapy.

  2024cites this paper
• Novel 2,6-disubstituted benzofuran-3-one analogues improve cerebral ischemia/reperfusion injury via neuroprotective and antioxidative effects.

  2023cites this paper
• Development of Pharmacological Strategies with Therapeutic Potential in Ischemic Stroke

  2023influential citation
• CysLT2R Antagonist HAMI 3379 Ameliorates Post-Stroke Depression through NLRP3 Inflammasome/Pyroptosis Pathway in Gerbils

  2022cites this paper
• Improving the Efficacy of Quinolylnitrones for Ischemic Stroke Therapy, QN4 and QN15 as New Neuroprotective Agents after Oxygen–Glucose Deprivation/Reoxygenation-Induced Neuronal Injury

  2022cites this paper
• Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke

  2022cites this paper
• Solvent-free synthesis of nitrone-containing template as a chemosensor for selective detection of Cu(II) in water.

  2021cites this paper
• Synthesis, Neuroprotection, and Antioxidant Activity of 1,1′-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models

  2021cites this paper
• Synthesis of New Statin Derivatives

  2021cites this paper
• 3D two-photon brain imaging reveals dihydroartemisinin exerts antiepileptic effects by modulating iron homeostasis.

  2021cites this paper
• Antioxidant for Neurological Diseases and Neurotrauma and Bioengineering Approaches

  2021cites this paper
• Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models

  2020cites this paper
• 5-Aryl-2-(3,5-dialkyl-4-hydroxyphenyl)-4,4-dimethyl-4H-imidazole 3-Oxides and Their Redox Species: How Antioxidant Activity of 1-Hydroxy-2,5-dihydro-1H-imidazoles Correlates with the Stability of Hybrid Phenoxyl–Nitroxides

  2020influential citation
• Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties

  2020cites this paper
• Recent Advances on Nitrones Design for Stroke Treatment.

  2020cites this paper
• Novel Quinolylnitrones Combining Neuroprotective and Antioxidant Properties.

  2019cites this paper
• Synthesis, neuroprotective and antioxidant capacity of PBN-related indanonitrones.

  2019cites this paper
• New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment.

  2019cites this paper
• Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia.

  2019cites this paper
• Neuroprotective Effects of Diets Containing Olive Oil and DHA/EPA in a Mouse Model of Cerebral Ischemia

  2019cites this paper
• Neuroprotective effect of FMS-like tyrosine kinase-3 silence on cerebral ischemia/reperfusion injury in a SH-SY5Y cell line.

  2019cites this paper
• Protective Effects of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate in a Rodent Model of Global Cerebral Ischemia

  2017cites this paper
• Nitrones, Old Fellows for New Therapies in Ischemic Stroke

  2017cites this paper